Discontinuation of Sotacor® Ampoules
HPS Pharmacies wish to advise that Aspen Pharma has given notice of the discontinuation of:
Sotalol hydrochloride 40mg/4mL
Therapeutic alternatives for intravenously administered sotalol will depend upon the indication and patient characteristics. The Australian Resuscitation Council publish guidelines for the management of acute dysrhythmias. Alternative therapies should be discussed with a cardiologist.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Aspen Pharma on 1300 659 646.
- Sotacor® (sotalol hydrochloride) Australian approved product information. Melbourne: Aspen Pharma. Approved March 2010.